216 related articles for article (PubMed ID: 29130644)
1. Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.
Lima VD; St-Jean M; Rozada I; Shoveller JA; Nosyk B; Hogg RS; Sereda P; Barrios R; Montaner JSG
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29130644
[TBL] [Abstract][Full Text] [Related]
2. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British Columbia, Canada: a population-level programme evaluation.
Lima VD; Zhu J; Barrios R; Toy J; Joy JB; Williams BG; Granich R; Wu Z; Wong J; Montaner JSG
Lancet HIV; 2024 Jul; 11(7):e461-e469. PubMed ID: 38848736
[TBL] [Abstract][Full Text] [Related]
4. Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada.
Tattersall T; Tam C; Moore D; Wesseling T; Grieve S; Wang L; Bacani N; Montaner JSG; Hogg RS; Barrios R; Salters K
BMC Public Health; 2022 May; 22(1):1022. PubMed ID: 35597938
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological impact of achieving UNAIDS 90-90-90 targets for HIV care in India: a modelling study.
Maddali MV; Gupta A; Shah M
BMJ Open; 2016 Jul; 6(7):e011914. PubMed ID: 27388363
[TBL] [Abstract][Full Text] [Related]
6. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
[TBL] [Abstract][Full Text] [Related]
7. 90-90-90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe - 2017 to 2020.
Bansi-Matharu L; Cambiano V; Apollo T; Yekeye R; Dirawo J; Musemburi S; Davey C; Napierala S; Fearon E; Mpofu A; Mugurungi O; Hargreaves JR; Cowan FM; Phillips AN
J Int AIDS Soc; 2018 Nov; 21(11):e25205. PubMed ID: 30465689
[TBL] [Abstract][Full Text] [Related]
8. A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study.
Nanditha NGA; Dong X; Tafessu HM; Wang L; Lu M; Barrios R; Montaner JSG; Lima VD
CMAJ Open; 2022; 10(1):E27-E34. PubMed ID: 35042692
[TBL] [Abstract][Full Text] [Related]
9. Implementation of HIV treatment as prevention strategy in 17 Canadian sites: immediate and sustained outcomes from a 35-month Quality Improvement Collaborative.
Clarke CM; Cheng T; Reims KG; Steinbock CM; Thumath M; Milligan RS; Barrios R
BMJ Qual Saf; 2016 May; 25(5):345-54. PubMed ID: 26208537
[TBL] [Abstract][Full Text] [Related]
10. Trends in plasma HIV-RNA suppression and antiretroviral resistance in British Columbia, 1997-2010.
Cescon A; Kanters S; Brumme CJ; Lepik KJ; Forrest JI; Hull M; Samji H; Nosyk B; Harrigan PR; Hogg RS; Montaner JS
J Acquir Immune Defic Syndr; 2014 Jan; 65(1):107-14. PubMed ID: 23978999
[TBL] [Abstract][Full Text] [Related]
11. Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.
Kim AA; Mukui I; N'gan'ga L; Katana A; Koros D; Wamicwe J; De Cock KM;
PLoS One; 2016; 11(3):e0148068. PubMed ID: 26930291
[TBL] [Abstract][Full Text] [Related]
12. Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response.
Baggaley R; Dalal S; Johnson C; Macdonald V; Mameletzis I; Rodolph M; Figueroa C; Samuelson J; Verster A; Doherty M; Hirnschall G
J Int AIDS Soc; 2016; 19(1):21348. PubMed ID: 27989271
[TBL] [Abstract][Full Text] [Related]
13. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.
Nosyk B; Montaner JSG; Colley G; Lima VD; Chan K; Heath K; Yip B; Samji H; Gilbert M; Barrios R; Gustafson R; Hogg RS;
Lancet Infect Dis; 2014 Jan; 14(1):40-49. PubMed ID: 24076277
[TBL] [Abstract][Full Text] [Related]
14. Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.
Nosyk B; Zang X; Min JE; Krebs E; Lima VD; Milloy MJ; Shoveller J; Barrios R; Harrigan PR; Kerr T; Wood E; Montaner JSG
Lancet HIV; 2017 Jul; 4(7):e303-e310. PubMed ID: 28366707
[TBL] [Abstract][Full Text] [Related]
15. Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.
Granich R; Gupta S; Hall I; Aberle-Grasse J; Hader S; Mermin J
PLoS Med; 2017 Apr; 14(4):e1002253. PubMed ID: 28376085
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.
Nosyk B; Min JE; Lima VD; Hogg RS; Montaner JS;
Lancet HIV; 2015 Sep; 2(9):e393-400. PubMed ID: 26423553
[TBL] [Abstract][Full Text] [Related]
17. Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada.
Bever A; Salters K; Tam C; Moore DM; Sereda P; Wang L; Wesseling T; Grieve S; Bingham B; Barrios R
BMJ Open; 2020 May; 10(5):e033649. PubMed ID: 32404387
[TBL] [Abstract][Full Text] [Related]
18. A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.
Olding M; Enns B; Panagiotoglou D; Shoveller J; Harrigan PR; Barrios R; Kerr T; Montaner JSG; Nosyk B
J Int AIDS Soc; 2017 Sep; 20(1):21941. PubMed ID: 28953322
[TBL] [Abstract][Full Text] [Related]
19. Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data.
Johnson LF; Kariminia A; Trickey A; Yiannoutsos CT; Ekouevi DK; Minga AK; Pascom ARP; Han WM; Zhang L; Althoff KN; Rebeiro PF; Murenzi G; Ross J; Hsiao NY; Marsh K
J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25776. PubMed ID: 34546623
[TBL] [Abstract][Full Text] [Related]
20. AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.
Lima VD; Lourenço L; Yip B; Hogg RS; Phillips P; Montaner JS
Lancet HIV; 2015 Mar; 2(3):e92-7. PubMed ID: 25780802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
